Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

9.95USD
15 Dec 2017
Change (% chg)

$0.11 (+1.12%)
Prev Close
$9.84
Open
$9.90
Day's High
$10.18
Day's Low
$9.80
Volume
221,862
Avg. Vol
65,696
52-wk High
$17.33
52-wk Low
$8.86

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.74 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 2
(2) OUTPERFORM 3 4 4 3
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.88 1.89 1.89 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 7 2.57 3.00 0.00 3.50
Quarter Ending Mar-18 2 13.00 23.00 3.00 --
Year Ending Dec-17 7 31.60 32.05 29.04 18.29
Year Ending Dec-18 8 16.01 42.00 0.00 18.99
Earnings (per share)
Quarter Ending Dec-17 7 -0.74 -0.67 -0.81 -0.72
Quarter Ending Mar-18 3 -0.51 -0.16 -0.73 --
Year Ending Dec-17 7 -2.24 -2.16 -2.31 -2.43
Year Ending Dec-18 8 -2.68 -1.70 -3.73 -2.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 16.00 23.01 7.01 43.82
Quarter Ending Jun-17 2.22 3.01 0.80 35.97
Quarter Ending Mar-17 2.29 3.02 0.73 31.85
Quarter Ending Dec-16 2.85 3.04 0.18 6.48
Quarter Ending Sep-16 10.38 13.02 2.64 25.45
Earnings (per share)
Quarter Ending Sep-17 -0.41 -0.17 0.24 -58.76
Quarter Ending Jun-17 -0.64 -0.69 0.05 -8.10
Quarter Ending Mar-17 -0.66 -0.63 0.03 -4.12
Quarter Ending Dec-16 -0.72 -0.63 0.09 -13.02
Quarter Ending Sep-16 -0.50 -0.46 0.04 -8.73

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2.57 2.57 2.33 3.44 3.50
Quarter Ending Mar-18 13.00 9.67 9.67 6.33 --
Year Ending Dec-17 31.60 31.60 29.14 25.46 18.29
Year Ending Dec-18 16.01 17.24 17.24 15.25 18.99
Earnings (per share)
Quarter Ending Dec-17 -0.74 -0.74 -0.75 -0.78 -0.72
Quarter Ending Mar-18 -0.51 -0.59 -0.59 -0.66 --
Year Ending Dec-17 -2.24 -2.24 -2.32 -2.51 -2.43
Year Ending Dec-18 -2.68 -2.72 -2.72 -2.86 -2.63

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0